Evidence map›Paper›PMID 40882322›Full record

ArticleBiomaterials2026

Injectable and self-healing fucoidan hydrogel: A natural anti-inflammatory biomaterial.

Shajia Afrin, Omanin Siddiqua Prova, Asma Talib Qureshi, Muhammad Waqas Ishaq, Cassandra E Callmann, Muhammad Rizwan

Abstract read
In one paragraph

Article in Biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shajia AfrinDepartment of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, 75235, TX, USA; Department of Biomedical Engineering, Michigan Technological University, Houghton, 49931, MI, USA.
Omanin Siddiqua ProvaDepartment of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, 75235, TX, USA.
Asma Talib QureshiDepartment of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, 75235, TX, USA.
Muhammad Waqas IshaqDepartment of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, 75235, TX, USA; Department of Chemistry, The University of Texas at Austin, Austin, 78712, TX, USA.
Cassandra E CallmannDepartment of Chemistry, The University of Texas at Austin, Austin, 78712, TX, USA.
Muhammad RizwanDepartment of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, 75235, TX, USA; Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, 75235, TX, USA. Electronic address: muhammad.rizwan@UTsouthwestern.edu.

Funding

Bioengineered corneal endothelial graft using photodegradable device to induce graft-host integrationR01EY035305 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI Muhammad Rizwan · 2023 to 2026
$1.5M
NEI NIH HHS R01 EY035305
6 · The paper itself

Abstract

Fucoidan, a natural sulfated polysaccharide, offers immense potential as a natural immune-modulatory bioactive polymer to develop hydrogels for tissue engineering. Yet, systematically tunable hydrogels composed primarily of fucoidan, that can also be injected into target tissues to reduce inflammation are still lacking. To address this, we have developed a highly tunable, hydrazone crosslinked fucoidan (hcFu) hydrogel that is injectable and can be utilized for various tissue engineering applications. We demonstrate that chemically modified fucoidan retains its ability to induce macrophage polarization. The hcFu hydrogel can be tuned to achieve gelation rate from instantaneous to over 10 min. Moreover, due to the dynamic nature of hydrazone covalent bonds, fucoidan hydrogel displays viscoelasticity, self-healing, extrudability, injectability, and excellent stability in physiological environments. In-vitro biocompatibility assays confirm its capacity to support cell growth, while in-vitro and in-vivo studies reveal its inherent anti-inflammatory and antioxidant effects. Importantly, hcFu hydrogel effectively modulates immune responses without incorporating additional cytokines. These findings position fucoidan hydrazone as a promising natural anti-inflammatory biomaterial with significant potential for tissue engineering and therapeutic applications.

Indexed as

Anti-Inflammatory AgentsBiocompatible MaterialsHydrogelsPolysaccharidesAnimalsHumansInjectionsMacrophagesMiceRAW 264.7 CellsTissue EngineeringAnti-Inflammatory AgentsBiocompatible MaterialsfucoidanHydrogelsPolysaccharidesBiocompatibilityFucoidanHydrogelImmunomodulationSelf-healing

Identifiers

PMID40882322
PMCPMC13482689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.